Pathan Nabira, Iadnut Anupon, Tewtrakul Supinya
Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai, Songkhla, 90112, Thailand; Department of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Prince of Songkla University, Songkhla, 90112, Thailand.
Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai, Songkhla, 90112, Thailand; Excellent Research Laboratory, Phytomedicine and Pharmaceutical Biotechnology Excellence Center, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai, Songkhla, 90112, Thailand; Department of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Prince of Songkla University, Songkhla, 90112, Thailand.
J Ethnopharmacol. 2024 Apr 24;324:117762. doi: 10.1016/j.jep.2024.117762. Epub 2024 Jan 14.
Kaempferia galanga L. is one of the important medicinal plants and has been used in Thailand for treating inflammation and wound.
This study aimed to investigate the efficacy of the compound from K. galanga on wound healing and anti-inflammatory activities and develop a new product in gel form to maximize the benefits of this plant.
The mouth gel containing kaempulchraol K (KG2) was prepared by using 1.5% carbopol 934 as a gelling agent. Formulations of mouth gel containing KG2 at 0.10%, 0.25%, and 0.50% w/w were evaluated for color, smell, pH values, viscosity, and separation. Also, the chemical and biological stabilities of mouth gel containing KG2 were evaluated by heating-cooling test. The anti-inflammatory activity was tested against RAW 264.7 cells nitric oxide (NO) production and wound healing assay was performed using human gingival fibroblasts (HGF).
Compound KG2 exhibited anti-NO production with an IC value of 66.8 μM and the wound healing activity of compound KG2 showed cell viability in the range of 90.9-111.4%. In addition, compound KG2 at a concentration of 3 μM induced the highest proportion of cell migration on day 3 at 90.2 ± 2.4%. The mouth gel containing KG2 both before and after the heating-cooling test exhibited good consistency, with pH values in the range of 6.64-6.71 (before) and 6.63-6.68 (after). Meanwhile, the viscosity was 81,700-96,700 cP (before) and 78,300-93,300 cP (after). For the chemical stability test of the active ingredient of mouth gel, the compound showed good stability after mixing with the gel base. The mouth gel exhibited anti-inflammation with IC values > 1000 μg/ml both before and after accelerating conditions. The wound healing activity of mouth gel containing KG2 (0.50% w/w) showed the highest % cell viability at 128.6% (before) and 123.8% (after). For cell migration, the result suggested that the mouth gel containing KG2 at 0.10%, 0.25%, and 0.50% w/w (3 μg/ml) on day 3 enhanced cell migration higher than that of the positive controls both before (85.0-96.8%) and after (and 84.4-94.3%) the accelerating conditions.
The present study shows that mouth gel containing 0.50% KG2 is the most appropriate with good physical, chemical, and biological stabilities and might be one of the alternative sources for treatment of mouth ulcers (oral stomatitis) derived from aphthous ulcers, chemotherapy, and radiotherapy treatments.
山奈是重要的药用植物之一,在泰国已被用于治疗炎症和伤口。
本研究旨在调查山奈中的化合物在伤口愈合和抗炎活性方面的功效,并开发一种凝胶形式的新产品,以最大限度地发挥这种植物的益处。
以1.5%的卡波姆934作为凝胶剂制备含山奈酚K(KG2)的口腔凝胶。对含0.10%、0.25%和0.50%(w/w)KG2的口腔凝胶配方进行颜色、气味、pH值、粘度和分离情况评估。此外,通过加热-冷却试验评估含KG2的口腔凝胶的化学和生物学稳定性。针对RAW 264.7细胞的一氧化氮(NO)生成测试抗炎活性,并使用人牙龈成纤维细胞(HGF)进行伤口愈合试验。
化合物KG2表现出抗NO生成活性,IC值为66.8 μM,其伤口愈合活性显示细胞活力在90.9 - 111.4%范围内。此外,浓度为3 μM的化合物KG2在第3天诱导细胞迁移的比例最高,为90.2 ± 2.4%。加热-冷却试验前后含KG2的口腔凝胶均表现出良好的稠度,pH值范围为6.64 - 6.71(加热前)和6.63 - 6.68(加热后)。同时,粘度分别为81,700 - 96,700 cP(加热前)和78,300 - 93,300 cP(加热后)。对于口腔凝胶活性成分的化学稳定性测试,该化合物与凝胶基质混合后显示出良好的稳定性。加速条件前后,口腔凝胶均表现出抗炎活性,IC值>1000 μg/ml。含KG2(0.50% w/w)的口腔凝胶的伤口愈合活性在加速条件前显示最高细胞活力百分比为128.6%,加速条件后为123.8%。对于细胞迁移,结果表明含0.10%、0.25%和0.50%(w/w)KG2(3 μg/ml)的口腔凝胶在第3天促进细胞迁移的能力高于阳性对照,加速条件前为85.0 - 96.8%,加速条件后为84.4 - 94.3%。
本研究表明,含0.50% KG2的口腔凝胶在物理、化学和生物学稳定性方面最为合适,可能是治疗由阿弗他溃疡、化疗和放疗引起的口腔溃疡(口腔炎)的替代药物来源之一。